Analystreport

Acceleron Pharma Inc (NASDAQ: XLRN) had its price target raised by analysts at SVB Leerink LLC from $104.00 to $127.00.

Acceleron Pharma Inc.  (XLRN) 
Last acceleron pharma inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.acceleronpharma.com/investor-relations